Terms & Conditions

These Terms & Conditions govern the purchase and use of products, laboratory services, software services, and related offerings made available by Supar.Health ApS through its websites, software platform, clinic network, laboratory workflows, and associated commercial channels. By purchasing, accessing, or using any Supar.Health service, you agree to be bound by these Terms & Conditions, unless a separate written agreement has been entered into between you and Supar.Health governing the relevant service.

Supar.Health ApS is a Danish company with registered address at Strandvejen 64, 2900 Hellerup, Denmark. References in these Terms & Conditions to “Supar.Health”, “we”, “us”, or “our” mean Supar.Health ApS. References to “you” mean the person or entity purchasing, accessing, or using the relevant service, whether as an individual end user, a clinic, a laboratory, or another authorized business customer.

1. Scope and Service Structure

Supar.Health operates as both a clinical diagnostics provider and a digital health platform. Our services may include the sale and coordination of suPAR testing services, the supply of sample collection kits and associated logistics, central or decentralized laboratory analysis, secure digital reporting, software subscriptions, hosting of user data, reporting engines, application programming interface access, and related bioinformatic or analytical tools.

The Supar.Health service environment supports three principal categories of customers. The first category is individual patients or end users. The second category is clinics, healthcare practices, or other medical organizations purchasing tests, software functionality, or associated laboratory services. The third category is laboratories and laboratory organizations purchasing access to our LIMS, reporting, or platform infrastructure and, in certain cases, reagent kits or related sample processing products.

Certain parts of the overall Supar.Health ecosystem are clinically regulated, while others are currently provided in research-use or investigational mode. The suPAR assay itself and the reported suPAR concentration are provided as clinically regulated outputs where performed within the applicable CE-IVD framework and associated laboratory procedures. By contrast, certain advanced software features, reporting layers, bioinformatic functions, and analytical interpretations available through the platform are currently made available for research, informational, health optimization, or investigational use only, pending completion of further regulatory processes. These distinctions will be identified where relevant in the platform, in supporting documentation, or in the applicable product description.

2. Customer Categories

Patients

A patient may purchase a suPAR test service directly from Supar.Health, including through our website or an affiliated clinic or partner flow. Where a patient purchases a test directly from Supar.Health, the purchase will ordinarily be fulfilled through a participating clinic selected by the patient. In such cases, the patient’s payment to Supar.Health operates as payment for a redeemable test service, typically implemented through a voucher or equivalent booking mechanism that is redeemed with the chosen clinic. The participating clinic will perform the relevant patient-facing service, including sample collection and, where applicable, clinical interpretation within that clinic’s own medical responsibility.

Patients may also subscribe directly to premium software functions made available through the Supar.Health platform. Such premium services may include secure hosting of user data, longitudinal result storage, advanced bioinformatic interpretation, dashboard functions, and related premium digital features. Where such services are offered on a subscription basis, they may be billed monthly or at such other recurring interval as specified at the time of purchase.

Clinics

Clinics may purchase suPAR test kits, laboratory analysis services, return shipping labels, software subscriptions, hosted access to the Supar.Health platform, reporting tools, and related services. Clinics may use the platform to manage patient workflows, receive or review test results, and access premium software functions, subject to the permissions, licensing, and regulatory scope applicable to the services selected.

Laboratories

Laboratories may purchase access to Supar.Health LIMS functionality and related reporting tools, including access via API or through the Supar.Health platform interface. Laboratory customers may also, in certain cases, purchase reagent kits, sample collection materials, and other operational products necessary to perform suPAR analysis or associated biomarker workflows. Laboratory subscriptions will generally include a platform fee based on users and functionality, hosting charges where applicable, and a per-report or per-test fee for generated outputs.

3. Ordering, Fulfilment, and Commercial Terms for Patients

Where a patient purchases a suPAR test service directly from Supar.Health, the order shall be deemed accepted once payment has been successfully completed and confirmation has been issued. The test service is then fulfilled through a selected participating clinic, and the clinic may receive a fee for sample collection, consultation, or related patient service as part of the commercial arrangement. Supar.Health retains the portion of the purchase price corresponding to the products, platform, laboratory analysis, logistics, and other agreed service components.

Any physical kit required for the patient service may be shipped either directly to the selected clinic or, where the chosen workflow allows, to another delivery destination approved by the clinic or indicated during the purchase process. Shipping costs are calculated per purchase and will be presented at or before checkout. Unless expressly stated otherwise, the patient is responsible for any import VAT, customs duty, local taxes, or similar charges arising in connection with international delivery. Supar.Health is not responsible for such charges and shall not be liable for delays, withholding, or additional costs arising from customs procedures or local import requirements.

Where a patient subscribes to premium software services, such services may renew automatically on a monthly or other recurring basis unless cancelled in accordance with the cancellation terms communicated at the time of purchase or made available within the user account.

4. Patient Cancellation, Withdrawal, and Refunds

Where a patient purchases products or services from Supar.Health as a consumer through distance selling channels, the patient may have statutory withdrawal rights in accordance with applicable consumer law. Unless a statutory exception applies, a patient may withdraw from an eligible purchase within fourteen days.

For physical goods, including unopened and unused kits or related materials that are capable of being returned in suitable condition, the withdrawal period shall run from the date of receipt. Returned goods must be unused, undamaged, and returned in a condition suitable for inspection and, where possible, resale. Unless otherwise required by law or expressly agreed by Supar.Health, the patient shall bear the cost of return shipment.

For diagnostic test services purchased directly from Supar.Health and fulfilled through a clinic voucher or equivalent mechanism, the patient may cancel and receive a full refund during the withdrawal period provided that no clinic booking has been confirmed, no kit has been dispatched, no laboratory processing has been initiated, and no part of the service has otherwise begun at the patient’s request. If the patient expressly requests that the service begin during the withdrawal period, including by confirming clinic redemption, requesting shipment, or initiating related processing steps, Supar.Health reserves the right to charge a proportionate amount corresponding to the part of the service already performed and to deduct any non-recoverable logistics or administrative costs already incurred. Once the relevant diagnostic service has been fully performed, any statutory withdrawal right shall cease to apply to the extent permitted by law.

For premium software subscriptions purchased directly by patients, the patient may cancel within the applicable withdrawal period unless the patient has expressly requested immediate access or activation and acknowledged that the right of withdrawal may be lost once performance has begun or the digital service has been supplied in accordance with applicable law. After the expiry of any applicable withdrawal period, subscription fees are non-refundable except where mandatory law provides otherwise.

5. Ordering, Fulfilment, and Commercial Terms for Clinics

Clinics may purchase test kits, laboratory analyses, shipping labels, software subscriptions, hosted storage, premium analytical functions, onboarding services, and related professional services from Supar.Health. Orders are binding once accepted by Supar.Health, whether through the website, a written quotation, an onboarding agreement, or another documented commercial process.

Shipping costs for kits, labels, or related materials are calculated at checkout or otherwise stated in the applicable quotation or commercial agreement. The clinic is solely responsible for any VAT, import duty, customs charge, local tax, or equivalent governmental fee associated with the purchase, importation, or use of such products and services, unless otherwise expressly agreed in writing.

A clinic subscription may include one or more of the following commercial elements: a one-time onboarding or setup fee, recurring subscription fees based on the number of users or enabled modules, fees for secure hosting of patient or clinic data, fees for premium software functionality, and per-test or per-report fees where applicable.

Unless otherwise agreed in writing, clinic subscriptions shall commence with a minimum binding term of six months. Upon expiry of the initial six-month term, the subscription shall renew automatically for successive renewal periods unless terminated in writing by either party with at least thirty days’ notice prior to the end of the then-current term. Supar.Health reserves the right to revise pricing or service structures on reasonable prior notice, provided that any already committed fixed term shall remain governed by the terms agreed for that term unless otherwise expressly stated.

For clinics outside the European Union, the regulatory classification and permitted marketing scope of the offered products and software may differ from the position applicable within the EU. In particular, while the suPAR assay may be supplied within the CE-IVD framework in relevant European markets, the same assay or associated service components may in other jurisdictions, including the United States, be offered only for Research Use Only and not for clinical diagnostic use, unless and until additional regulatory clearance or approval has been obtained. The clinic is responsible for ensuring that its use of any purchased product or software complies with local law, local regulatory requirements, and the intended use designation applicable in the relevant jurisdiction.

6. Failed Samples and Sample Quality Requirements for Clinics

Samples submitted for analysis must meet the applicable technical, pre-analytical, handling, storage, packaging, transport, labeling, and timing requirements specified by Supar.Health, the relevant laboratory protocol, and any applicable instructions for use. Proper sample quality and integrity are essential to enable valid and reliable analysis.

If a sample arrives damaged, degraded, mislabeled, contaminated, improperly stored, delayed beyond acceptable limits, or otherwise unsuitable for analysis, or if it has not been collected, handled, or shipped in accordance with the applicable protocol, the sample may be designated as failed or rejected. In such circumstances, Supar.Health shall not be responsible for replacement sampling, replacement materials, or any associated patient-facing or operational costs incurred by the clinic, except to the extent that the sample failure is directly attributable to a fault for which Supar.Health is legally responsible.

A failed sample may give rise to additional fees, including fees for administrative handling, repeat logistics, or repeat analysis, depending on the circumstances and the applicable commercial arrangement. In certain cases, and at Supar.Health’s sole discretion or where expressly agreed, all or part of the analysis charge may be credited, particularly where the failed sample cannot reasonably be attributed to the clinic, patient handling, or transport conditions outside Supar.Health’s control. Any such credit shall be a commercial adjustment and shall not constitute an admission of liability.

Where a patient-facing service is performed through a clinic, the clinic remains solely responsible toward the patient for sample collection quality, protocol adherence, and management of any failed sample event, including re-sampling, patient communication, and any associated clinical or service obligations.

1. Ordering, Fulfilment, and Commercial Terms for Laboratories

Laboratory customers may purchase access to Supar.Health LIMS functionality, software modules, API integrations, report-generation tools, and associated hosting services. Such services may be provided as text-based API outputs for integration into an existing laboratory information system or via the Supar.Health platform itself.

Laboratory purchases may also include, where offered, access to reagent kits supplied by ViroGates or other designated suppliers, sample draw kits, calibration materials, controls, and related laboratory consumables. In addition to any product charges, a laboratory customer’s subscription will ordinarily include a platform subscription fee calculated according to the number of users, features enabled, or organizational scope of the implementation, together with hosting fees and usage-based charges, including charges per generated test report or analytical output where applicable.

Unless otherwise agreed in writing, laboratory subscriptions shall commence with a minimum binding term of six months. Upon expiry of the initial six-month term, the subscription shall renew automatically for successive renewal periods unless terminated in writing by either party with at least thirty days’ notice prior to the end of the then-current term.

The laboratory remains responsible for ensuring that any use of purchased products, software outputs, or reports is consistent with the applicable intended use, accreditation standards, laboratory regulations, and the legal framework governing the relevant territory.

7. Billing and Payment

All fees are payable in the currency and by the payment method specified at the time of order, invoicing, or subscription signup, unless otherwise agreed in writing. Supar.Health reserves the right to require advance payment for products, subscriptions, kits, analyses, onboarding, or other services.

Recurring software subscriptions shall renew automatically for successive billing periods unless cancelled before the next renewal date in accordance with the applicable cancellation process. Failure to pay any invoice, subscription amount, or other due charge may result in suspension of access to the relevant services, delayed processing of orders, withholding of reports, or termination of the affected account or agreement, subject to applicable law and any mandatory professional obligations.

Unless otherwise stated, all prices are exclusive of shipping, customs costs, VAT, import taxes, local duties, or other governmental charges. Such amounts shall be borne by the purchasing customer.

8. Shipping, Delivery, and Logistics

Where Supar.Health arranges the shipment of kits, labels, or related materials, delivery times are estimates only and not guaranteed, unless expressly stated otherwise in writing. Risk in physical goods shall pass in accordance with the agreed delivery terms or, if no specific delivery term has been agreed, when the goods are delivered to the carrier or made available to the customer, as appropriate under the transaction structure.

Customers are responsible for providing accurate shipping details and for ensuring that imported goods may lawfully be received in the relevant jurisdiction. Supar.Health shall not be liable for customs delays, seizure, additional local charges, or delivery disruption caused by incorrect delivery information, local import restrictions, force majeure, or third-party carrier failures.

9. Clinical Services, Medical Responsibility, and Role Allocation

Where a patient purchases a test service fulfilled through a participating clinic, the clinic remains responsible for the patient-facing medical relationship, including sample collection, the exercise of clinical judgment, interpretation of results in the broader medical context, and compliance with applicable medical record and consent obligations. Supar.Health may provide products, central laboratory analysis, digital infrastructure, and reporting support, but the existence and scope of medical responsibility depends on the specific service model and the role of the participating healthcare provider.

Where a sample fails or is rejected in a patient-facing clinic workflow, the operating clinic bears sole responsibility toward the patient for handling that event, including any re-sampling, communication, and follow-up obligations, except where mandatory law imposes non-excludable responsibility on another party.

Where Supar.Health itself operates or oversees a laboratory function, it does so within the scope of the applicable laboratory and regulatory framework. Where a laboratory or clinic uses the Supar.Health platform independently, that organization remains responsible for its own legal compliance, data governance, medical responsibility, and any patient communication or clinical use of the outputs, except to the extent that responsibility is explicitly assumed by Supar.Health in a separate written agreement.

10. Regulated Outputs and Research Use Only Outputs

Supar.Health distinguishes between regulated diagnostic outputs and software-enabled outputs that are presently provided in investigational, informational, or Research Use Only mode. The suPAR test result itself, when generated through the applicable CE-IVD assay and corresponding laboratory workflow, is intended as a clinically regulated biomarker result within the scope of the relevant assay and laboratory process. However, parts of the reporting engine, dashboard functionality, advanced bioinformatic interpretation, risk stratification layers, biological age estimates, community-derived comparison models, and certain algorithmic or longitudinal features currently operate outside final medical-device certification and are therefore provided for research, information, wellness, or decision-support purposes only, and not as independently certified medical device outputs.

Such RUO or investigational outputs must not be used as the sole basis for diagnosis, treatment, emergency decisions, prescribing, or other medical interventions. They are intended to supplement, and not replace, professional medical evaluation and clinically validated diagnostic information.

11. Software License and Platform Use

Subject to compliance with these Terms & Conditions and payment of all applicable fees, Supar.Health grants the relevant customer a limited, non-exclusive, non-transferable, non-sublicensable right to access and use the software platform, user interface, reporting engine, API, and associated functionality solely for the customer’s internal and permitted use in accordance with the purchased service.

The platform, source code, software architecture, analytical methods, interfaces, databases, visualizations, reports, trademarks, and all related intellectual property rights remain the exclusive property of Supar.Health or its licensors. The customer shall not copy, reverse engineer, modify, decompile, extract, republish, resell, or otherwise exploit the platform or its components except to the extent expressly permitted by mandatory law or by a separate written agreement.

12. Data, Privacy, and User Rights

Use of the Supar.Health services involves the processing of personal data, including health data. Such processing is governed by the applicable Privacy Policy, data processing agreements, consent flows, and, where relevant, clinic or laboratory onboarding documents. Patients retain the rights granted to them by applicable data protection law in relation to their identifiable personal data. Clinics and laboratories remain responsible for the lawfulness of their own processing where they act as independent data controllers.

Supar.Health does not claim ownership of a patient’s personal data as such. However, where data has been lawfully anonymized in such a way that no individual may be identified directly or indirectly, Supar.Health may retain and use such anonymized data for research, development, analytics, software improvement, bioinformatic model training, artificial intelligence development, and commercial purposes, including collaboration, licensing, and platform-wide improvement. This principle is further described in the Privacy Policy and any applicable separate consent documentation.

13. Service Changes, Availability, and Updates

Supar.Health may from time to time modify, improve, update, suspend, or discontinue parts of its products or software services in order to maintain security, stability, regulatory compliance, or technical performance. This may include updates to user interfaces, functionality, pricing structures, subscription plans, API formats, data models, workflows, and report layouts.

We will seek to provide reasonable notice where changes materially affect paid services. However, we reserve the right to implement urgent modifications without prior notice where necessary to address security risks, legal requirements, system integrity, or patient safety concerns.

14. Term, Cancellation, Suspension, and Termination

Unless otherwise agreed in writing, subscriptions continue for the minimum term and any subsequent renewal period unless cancelled in accordance with the applicable notice provisions. One-time purchases, including test purchases, kit purchases, or onboarding fees, are non-cancellable once the relevant order has been accepted and processing, shipment, booking, or provisioning has begun, except where mandatory consumer law requires otherwise.

Supar.Health may suspend, revoke, or terminate access to the platform and related services with immediate effect upon breach by a clinic, laboratory, or other business customer. This includes, without limitation, breach of payment obligations, misuse of regulated or RUO outputs, unlawful use, unauthorized access, misuse of patient data, cybersecurity or confidentiality failures, regulatory non-compliance, misuse of the reporting environment, or any conduct that may expose Supar.Health, patients, clinics, laboratories, or other users to legal, safety, regulatory, or operational risk.

Such immediate suspension, revocation, or termination shall not affect accrued payment obligations, confidentiality obligations, intellectual property protections, liability limitations, or any provision intended by its nature to survive termination.

15. Warranties and Limitations

Supar.Health will use reasonable professional care in providing its products and services. However, except to the extent that a specific warranty is required by law or expressly set out in writing, the software platform and its non-regulated features are provided on an “as is” and “as available” basis. We do not warrant that the platform will be uninterrupted, error-free, or suitable for every user purpose, workflow, or regulatory environment.

Clinical laboratory analysis is performed in accordance with the applicable assay, laboratory procedures, and quality systems, but biological and technical variability remains inherent in laboratory medicine. Except where prohibited by law, Supar.Health disclaims warranties of merchantability, fitness for a particular purpose, uninterrupted availability, and non-infringement in relation to the software environment and other non-regulated digital features.

16. Limitation of Liability

To the fullest extent permitted by applicable law, Supar.Health shall not be liable for any indirect, incidental, special, consequential, punitive, or purely economic loss, including loss of profit, loss of business opportunity, loss of reputation, or loss of data, arising out of or in connection with the use of the services, except where such limitation is prohibited by mandatory law.

To the extent permitted by law, Supar.Health’s total aggregate liability arising under or in connection with these Terms & Conditions shall not exceed the amount paid by the relevant customer to Supar.Health for the specific product or service giving rise to the claim during the twelve-month period preceding the event giving rise to liability. Nothing in these Terms & Conditions shall exclude or limit liability that cannot lawfully be excluded, including liability for fraud, fraudulent misrepresentation, or death or personal injury caused by negligence where such exclusion is not permitted.

17. Governing Law and Jurisdiction

These Terms & Conditions shall be governed by and construed in accordance with the laws of Denmark, without regard to conflict-of-law principles. Any dispute arising out of or in connection with these Terms & Conditions shall be subject to the jurisdiction of the Danish courts, unless mandatory consumer protection law provides otherwise.

18. Changes to These Terms

Supar.Health may amend these Terms & Conditions from time to time in order to reflect changes in law, regulatory position, product design, pricing models, technical infrastructure, or commercial structure. The most recent version will be made available through the website or platform. Where material changes affect ongoing subscriptions or established customer relationships, we will provide reasonable notice in accordance with applicable law.

V1.260326.1025

Date: 26.03.2026